#ArtharaStocksHunt with https://t.co/RkgTrizQ0W - based on 22/07
@klinikp88@notintofinance@arthara_id
While sorting through the Arthara screener I came across this set of stocks that is aligned with its accumulation/mark up Wyckoff structure and still below on it's VWAP-
Bitcoin just broke the most important level in finance.
Time to retire the yellow squiggle.
Only 2 paths left, in either case, all dips, for me, are for buying:
Timing wise, nothing changes, just the lows might be higher lows.
Good times are right around the corner 🥂
A HUGE LIQUIDITY CRISIS IS UNFOLDING IN TURKEY RIGHT NOW.
One of Turkey’s biggest fund managers failed to meet investor withdrawal requests.
Then another manager reported the same problem with $7.5 billion worth of funds.
Investors rushed for the exits, pulling as much as $1 billion from funds in a single day.
Turkish stocks dropped more than 6%, after already falling over 2% the day before.
Now authorities are stepping in.
Interbank borrowing limits have been increased 10X, while several funds are being liquidated.
The scary part is what happens next.
Funds need cash to pay investors, so they sell assets.
Prices fall, and more investors panic and ask for their money back.
If that cycle keeps going, Turkey’s liquidity problem can get much worse very fast.
$BTC UPDATE
Range thesis invalidated. Price closed above 79.5k and expanded into 80.7k, which is exactly the condition I wrote as the invalidation.
79.5k is the level that matters now. Held as support, the expansion stays intact. Back inside the range, the break was a fakeout.
$BTC 30M
Monday range is doing the work here. Holding above the OB at 64.1k keeps monH 64.6k as the draw.
Lose it and 64k opens up, with monEQ 63.6k underneath. A flush into monO and monL near 62.9k is the deep option, and that is where I would rather be bidding than chasing.
Continuation invalid on a 30m close below 64.1k.
Saham Moderna hari ini naik 130%+ karena Moderna & Merck baru rilis hasil uji klinis fase 3 buat vaksin kanker kulit (melanoma) yang mereka kembangkan bareng.
Namanya intismeran, vaksin mRNA yang dibuat khusus sesuai profil genetik tumor tiap pasien, dikombinasikan sama obat imunoterapi Keytruda.
Hasilnya signifikan: Pasien yang dapet kombinasi ini jauh lebih kecil kemungkinan kankernya kambuh atau menyebar, dibanding yang cuma dapet Keytruda aja. Diuji ke lebih dari 1.100 pasien melanoma stadium tinggi.
Ini pertama kalinya terapi kanker berbasis mRNA lolos uji klinis fase akhir. Kalau nanti disetujui regulator, bisa jadi standar pengobatan baru buat melanoma pasca operasi.
Visa sponsorship + Remote jobs + Freshly funded startups:
European Tech Visa Sponsorship
https://t.co/ABgF4qHgGE
US Tech Visa Sponsorship
https://t.co/po7seD1Emj
Japan Tech Visa Sponsorship
https://t.co/AcsVOyNTs5
150 Remote Companies Hiring
https://t.co/AeykzYnjRs
100% Remote Hiring Companies
https://t.co/4zgjNrfV0R
400+ San Francisco Bay Area companies
https://t.co/uLmPgvUNrl
1500+ Recent Funding Startups
https://t.co/qKhTjz6wqf
Indian Startups Freshers DS/ML/AI Hiring 2026
https://t.co/UB4KxiIKpX
Indian Robotics Startups Database
https://t.co/kzj5SWYMU2
1300+ Hidden Companies Hiring List
https://t.co/PTZT3ccqlo
Bookmark it.
Repost it to help others.
Share with your friends.
VWAP bands are live on Arthara.
Anchor to the quarter or the year. You get the running VWAP with its ±1σ and ±2σ bands, plus last period's levels, all labeled on the chart itself.
Works on every ticker.
Checkout it out now at https://t.co/OYoq8QLQij